Results 1 - 5 of 17 for: "Arzerra"
Refine your search:

Arzerra
The U.S. Food and Drug Administration has approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia.
Consumer Information (Drugs.com) · More like this · Add to my drug list

Arzerra
ARZERRA (ofatumumab) is an IgG1κ human monoclonal antibody with a molecular weight of approximately 149 kDa. The antibody was generated via transgenic mouse and hybridoma technology and is produced in a recombinant murine cell line (NS0) using standard mammalian cell cultivation and...
Professional Monographs (FDA) · More like this · Add to my drug list

Arzerra Approved for Chronic Lymphocytic Leukemia
TUESDAY, Oct. 27 -- Arzerra (ofatumumab) has been approved by the U.S. Food and Drug Administration to treat chronic lymphocytic leukemia (CLL), a cancer of the blood and bone marrow. The drug, produced by London-based GlaxoSmithKline, is approved when other types of chemotherapy no longer control...
News & Articles (Drugs.com) · More like this

FDA Approves Arzerra (ofatumumab) for Chronic Lymphocytic Leukemia
SILVER SPRING. Md., Oct. 26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic lymphocytic leukemia (CLL), a slowly progressing cancer of the blood and bone marrow. Arzerra is approved...
New Drug Approvals (FDA) · More like this

Arzerra (Ofatumumab) Granted Priority Review By FDA
...April 3, 2009 Genmab today announced that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for Arzerra (ofatumumab) to treat patients whose chronic lymphocytic leukemia (CLL) is resistant (refractory) to previous therapies and has granted ofatumumab...
New Drug Applications (FDA) · More like this

See also: Chronic Lymphocytic Leukemia

Having trouble finding what you want?


MedNotes
Advertisement

(web4)